A great weekend at @RPANephrology conference. Capped it off with the clinical session day. @NephroShah @edgarvlermamd @SWadhwaniMD @NWiegley @SwethaKanduriMD

Great to be at #kidneywk in Houston! Nice weather and nice to see so many colleagues excited about treating and improving kidney disease

Today I had a clinic patient referral for a lady that’s 80 years old. Her hypertension and mild CKD regimen is likely being prescribed by a doctor older than her: diltiazem and triamterene. The markers of an old prescriber that hasn’t kept up with the HTN/CKD renaissance.

Spotted in the Amsterdam airport: this popular Dutch black candy is legendary for leading to hypertension and electrolyte abnormalities when consumed in high quantities. What is the disorder?

It was a great experience with American Kidney Fund discussing how to better diagnosis unknown kidney disease. We need to check UACR and promote genetic testing at a much higher rate. Too complacency with DKD. And a morning run at the WH fortress. @DiMiRenalMD

Steroidal vs Nonsteroidal MRAs – Same target, different impact 🔹Steroidal: higher kidney vs heart binding, more off-target effects 🔹Nonsteroidal: balanced binding, tighter antagonism, proven HFpEF benefit 👉 https://t.co/ngoKasNk63 🆕 #CardioTwitter #NephTwitter #HF #MRAs

Let’s help patients on dialysis therapy keep their coverage they need to get quality care they deserve. #opinion ⁦@NKFTexas⁩ ⁦@dallasnews⁩

Breaking: the new Apple Watch will try to determine if you have hypertension. They expect to help alert 1,000,000 people in the next year. Lofty claims - we will see! @Apple

We had a great @DallasCMS Medical Student Mixer this weekend. Glad to have @texmed President Jay Shah MD join us. @UTSWMedCenter @TAMUmedicine

New 2025 Blood Pressure Guidelines are out. Lower and tighter control is recommended. Cut the salt 🧂 https://t.co/ko58Uj0bwB

Enjoyed working with @KidneyFund and @NateraGenetics to hear the patient voice and perspective on transplant monitoring at WTC. Awesome panel including Daniel with a 9yr going strong pediatric transplant 💪🏻

Here with @NKFTexas at the Renal Roundtable learning about C3 GN advances from Dr Saxena. Tough disease but new promises being approved. @UTSWNephrology @DiMiRenalMD

@HecmagsMD @M_Elraggal

@HecmagsMD

Need to brush up on Sparsentan, a DEARA for IgA Nephropathy? Check out our recent review. Including a VA from @NephJC. @edgarvlermamd @AnnaGaddy https://t.co/x0hrBAKQDy

Sparsentan: a dual endothelin and angiotensin II receptor antagonist (DEARA) approved for IgA nephropathy (IgAN) ca 2025 from @DoctorGates @HecmagsMD @AnnaGaddy @M_Elraggal #Nephpearls https://t.co/SLphc8CM4k

It would be kind of funny if AI ended up getting stupider over time b/c of all the dumb stuff we put on the internet

Central Texas Flooding Relief: The devastating floods that have swept through Hill Country over the past three days have left families displaced, homes destroyed, and communities in crisis. Donate: DCMS Foundation Disaster Relief Fund Volunteer: Register on our website

I recently joined @DoctorGates for two mini episodes on #C3G, where we discussed diagnostic challenges & emerging treatments. Grateful for the opportunity to contribute to the conversation & share what we’re learning!! https://t.co/HuwgGlEwVj https://t.co/JyKCoSgQTk

Optimization of Renin-Angiotensin-Aldosterone Inhibitor (RASi) Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community ca. 2025 from @KIReports @ISNkidneycare @goKDIGO @RPANephrology @ASPCardio #Nephpearls #Cardiorenal 👉🏼

❤️ May is National High Blood Pressure Education Month! Hypertension is the “silent killer”—often with no symptoms. Regular checks can help prevent heart disease. 🩺🫀 #TXACP #HeartHealth #Hypertension #PreventativeHealth #InternalMedicine